Table 1.
Outcome of meningococcal disease and treatment with serum therapy*
|
Serum-treated patients |
Untreated patients |
Type of serum | ||
|---|---|---|---|---|
| Number | Mortality (%) | Mortality (%) | ||
| Steiner | 2280 | 37·0 | 77·0 | Flexner |
| Flexner | 1294 | 30·9 | 75·0 | Flexner |
| Robb | 300 | 30·0 | 72·0 | Flexner |
| Sophian | 161 | 15·5 | No available data | Flexner |
| Netter | 100 | 28·0 | 49·0 | Dopter |
| Dopter | 402 | 16·4 | 65·0 | Dopter |
| Levy | 165 | 18·2 | 52·1 | Dopter |
| Krohne | 59 | 40·6 | 66·0 | Kolle and Wassermann |
| Leick | 34 | 32·4 | 55·0 | Kolle and Wassermann |
| Neglein | 30 | 26·6 | 50·0 | Kolle and Wassermann |
| Tobben | 29 | 34·0 | 56·0 | Kolle and Wassermann |
| Kleinschmidt | 21 | 19·0 | 62·5 | Kolle and Wassermann |
| Quenstedt | 18 | 22·2 | 56·2 | Kolle and Wassermann |
| Jehle | 41 | 45·0 | 70·0 | Markl |
| Weiss and Eder | 23 | 39·0 | 85·0 | Markl |
| Schoene | 30 | 25·0 | 53·0 | Jochmann |
| Total | 4987 | 28·7 | 60·1 | .. |